SCHOLAR ROCK HOLDING CORPORATION Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
SCHOLAR ROCK HOLDING CORPORATION (SRRK) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of $451.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-08-06
- SCHOLAR ROCK HOLDING CORPORATION other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-06-30 was $451.00K.
- SCHOLAR ROCK HOLDING CORPORATION other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was $596.00K.
- SCHOLAR ROCK HOLDING CORPORATION other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-12-31 was -$23.00K, a 171.88% decline year-over-year.
- SCHOLAR ROCK HOLDING CORPORATION other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-09-30 was $59.00K, a 67.58% decline year-over-year.
- SCHOLAR ROCK HOLDING CORPORATION other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2025 was -$66.00K, a 197.06% decline from fiscal 2024.
- SCHOLAR ROCK HOLDING CORPORATION other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was $68.00K, a 93.03% decline from fiscal 2023.
- SCHOLAR ROCK HOLDING CORPORATION other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was $976.00K.
- SCHOLAR ROCK HOLDING CORPORATION other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2022 was -$849.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | $451.00K 10-Q · filed 2026-08-06 | $1.05M 10-Q · filed 2026-08-06 | $1.02M derived: sum of 3 quarters · filed 2026-08-06 | $1.08M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $596.00K 10-Q · filed 2026-05-07 | $573.00K derived: sum of 2 quarters · filed 2026-05-07 | $632.00K derived: sum of 3 quarters · filed 2026-05-07 | $561.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$23.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $36.00K derived: sum of 2 quarters · filed 2026-03-03 | -$35.00K derived: sum of 3 quarters · filed 2026-08-06 | -$66.00K 10-K · filed 2026-03-03 |
| 2025-09-30 | $59.00K 10-Q · filed 2025-11-14 | -$12.00K derived: sum of 2 quarters · filed 2026-08-06 | -$43.00K 10-Q · filed 2025-11-14 | -$11.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$71.00K 10-Q · filed 2026-08-06 | -$102.00K 10-Q · filed 2026-08-06 | -$70.00K derived: sum of 3 quarters · filed 2026-08-06 | $112.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$31.00K 10-Q · filed 2026-05-07 | $1.00K derived: sum of 2 quarters · filed 2026-05-07 | $183.00K derived: sum of 3 quarters · filed 2026-05-07 | $179.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $32.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $214.00K derived: sum of 2 quarters · filed 2026-03-03 | $210.00K derived: sum of 3 quarters · filed 2026-03-03 | $68.00K 10-K · filed 2026-03-03 |
| 2024-09-30 | $182.00K 10-Q · filed 2025-11-14 | $178.00K derived: sum of 2 quarters · filed 2025-11-14 | $36.00K 10-Q · filed 2025-11-14 | $151.00K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | -$4.00K 10-Q · filed 2025-08-06 | -$146.00K 10-Q · filed 2025-08-06 | -$31.00K derived: sum of 3 quarters · filed 2025-08-06 | $9.00K derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | -$142.00K 10-Q · filed 2025-05-14 | -$27.00K derived: sum of 2 quarters · filed 2025-05-14 | $13.00K derived: sum of 3 quarters · filed 2025-05-14 | $279.00K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $115.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $155.00K derived: sum of 2 quarters · filed 2025-02-27 | $421.00K derived: sum of 3 quarters · filed 2025-02-27 | $976.00K 10-K · filed 2025-02-27 |
| 2023-09-30 | $40.00K 10-Q · filed 2024-11-12 | $306.00K derived: sum of 2 quarters · filed 2024-11-12 | $861.00K 10-Q · filed 2024-11-12 | $913.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $266.00K 10-Q · filed 2024-08-08 | $821.00K 10-Q · filed 2024-08-08 | $873.00K derived: sum of 3 quarters · filed 2024-08-08 | $16.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $555.00K 10-Q · filed 2024-05-07 | $607.00K derived: sum of 2 quarters · filed 2024-05-07 | -$250.00K derived: sum of 3 quarters · filed 2024-05-07 | -$177.00K derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $52.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | -$805.00K derived: sum of 2 quarters · filed 2024-03-19 | -$732.00K derived: sum of 3 quarters · filed 2024-03-19 | -$849.00K 10-K · filed 2024-03-19 |
| 2022-09-30 | -$857.00K 10-Q · filed 2023-11-07 | -$784.00K derived: sum of 2 quarters · filed 2023-11-07 | -$901.00K 10-Q · filed 2023-11-07 | -$936.00K derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $73.00K 10-Q · filed 2023-08-09 | -$44.00K 10-Q · filed 2023-08-09 | -$79.00K derived: sum of 3 quarters · filed 2023-08-09 | -$88.00K derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | -$117.00K 10-Q · filed 2023-05-09 | -$152.00K derived: sum of 2 quarters · filed 2023-05-09 | -$161.00K derived: sum of 3 quarters · filed 2023-05-09 | -$175.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | -$35.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | -$44.00K derived: sum of 2 quarters · filed 2023-03-07 | -$58.00K derived: sum of 3 quarters · filed 2023-03-07 | -$33.00K 10-K · filed 2023-03-07 |
| 2021-09-30 | -$9.00K 10-Q · filed 2022-11-14 | -$23.00K derived: sum of 2 quarters · filed 2022-11-14 | $2.00K 10-Q · filed 2022-11-14 | -$3.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$14.00K 10-Q · filed 2022-08-08 | $11.00K 10-Q · filed 2022-08-08 | $6.00K derived: sum of 3 quarters · filed 2022-08-08 | -$40.00K derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $25.00K 10-Q · filed 2022-05-16 | $20.00K derived: sum of 2 quarters · filed 2022-05-16 | -$26.00K derived: sum of 3 quarters · filed 2022-05-16 | -$211.00K derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | -$5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-07 | -$51.00K derived: sum of 2 quarters · filed 2022-03-07 | -$236.00K derived: sum of 3 quarters · filed 2022-03-07 | -$39.00K 10-K · filed 2022-03-07 |
| 2020-09-30 | -$46.00K 10-Q · filed 2021-11-09 | -$231.00K derived: sum of 2 quarters · filed 2021-11-09 | -$34.00K 10-Q · filed 2021-11-09 | -$23.00K derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | -$185.00K 10-Q · filed 2021-08-10 | $12.00K 10-Q · filed 2021-08-10 | $23.00K derived: sum of 3 quarters · filed 2021-08-10 | -$9.00K derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | $197.00K 10-Q · filed 2021-05-13 | $208.00K derived: sum of 2 quarters · filed 2021-05-13 | $176.00K derived: sum of 3 quarters · filed 2021-05-13 | $218.00K derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | -$21.00K derived: sum of 2 quarters · filed 2021-03-09 | $21.00K derived: sum of 3 quarters · filed 2021-03-09 | $45.00K 10-K · filed 2021-03-09 |
| 2019-09-30 | -$32.00K 10-Q · filed 2020-11-09 | $10.00K derived: sum of 2 quarters · filed 2020-11-09 | $34.00K 10-Q · filed 2020-11-09 | $26.00K derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $42.00K 10-Q · filed 2020-08-07 | $66.00K 10-Q · filed 2020-08-07 | $58.00K derived: sum of 3 quarters · filed 2020-08-07 | $58.00K derived: sum of 4 quarters · filed 2020-08-07 |
| 2019-03-31 | $24.00K 10-Q · filed 2020-05-07 | $16.00K derived: sum of 2 quarters · filed 2020-05-07 | $16.00K derived: sum of 3 quarters · filed 2020-05-07 | $18.00K derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | -$8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$8.00K derived: sum of 2 quarters · filed 2020-03-12 | -$6.00K derived: sum of 3 quarters · filed 2020-03-12 | -$6.00K 10-K · filed 2020-03-12 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $2.00K derived: sum of 2 quarters · filed 2019-11-12 | $2.00K 10-Q · filed 2019-11-12 | $7.00K derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $2.00K 10-Q · filed 2019-08-14 | $2.00K 10-Q · filed 2019-08-14 | $7.00K derived: sum of 3 quarters · filed 2019-08-14 | $20.00K derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-03-31 | $1.00K 10-Q · filed 2019-05-15 | $5.00K derived: sum of 2 quarters · filed 2019-05-15 | $18.00K derived: sum of 3 quarters · filed 2019-05-15 | $22.00K derived: sum of 4 quarters · filed 2019-05-15 |
| 2017-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-19 | $17.00K derived: sum of 2 quarters · filed 2019-03-19 | $21.00K derived: sum of 3 quarters · filed 2019-03-19 | $18.00K 10-K · filed 2019-03-19 |
| 2017-09-30 | $13.00K 10-Q · filed 2018-11-08 | $17.00K derived: sum of 2 quarters · filed 2018-11-08 | $14.00K 10-Q · filed 2018-11-08 | |
| 2017-06-30 | $4.00K 10-Q · filed 2018-08-08 | $1.00K 10-Q · filed 2018-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |